DrugPatentWatch Database Preview
Anchen Pharms Company Profile
What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?
ANCHEN PHARMS has twenty-six approved drugs.
There are two tentative approvals on ANCHEN PHARMS drugs.
Summary for Anchen Pharms
| US Patents: | 0 |
| Tradenames: | 22 |
| Ingredients: | 22 |
| NDAs: | 26 |
Drugs and US Patents for Anchen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anchen Pharms | TRETINOIN | tretinoin | CAPSULE;ORAL | 201687-001 | Oct 24, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Anchen Pharms | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 201573-001 | Jul 18, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Anchen Pharms | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 091360-002 | Oct 4, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Anchen Pharms | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091459-003 | Jun 9, 2011 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Anchen Pharms | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202206-003 | Feb 6, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Anchen Pharms | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202984-001 | Sep 30, 2013 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
